Sargent Investment Group’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-200
| Closed | -$55K | – | 195 |
|
|
2021
Q3 | $55K | Hold |
200
| – | – | 0.01% | 185 |
|
|
2021
Q2 | $79K | Sell |
200
-33
| -14% | -$13K | 0.02% | 190 |
|
|
2021
Q1 | $126K | Sell |
233
-357
| -61% | -$193K | 0.03% | 182 |
|
|
2020
Q4 | $223K | Sell |
590
-1,337
| -69% | -$505K | 0.07% | 158 |
|
|
2020
Q3 | $728K | Buy |
1,927
+380
| +25% | +$144K | 0.26% | 72 |
|
|
2020
Q2 | $759K | Buy |
1,547
+10
| +0.7% | +$4.91K | 0.29% | 66 |
|
|
2020
Q1 | $565K | Sell |
1,537
-167
| -10% | -$61.4K | 0.26% | 70 |
|
|
2019
Q4 | $1.21M | Buy |
1,704
+99
| +6% | +$70.1K | 0.44% | 47 |
|
|
2019
Q3 | $1.03M | Buy |
1,605
+159
| +11% | +$102K | 0.46% | 53 |
|
|
2019
Q2 | $1.27M | Buy |
1,446
+113
| +8% | +$98.9K | 0.58% | 38 |
|
|
2019
Q1 | $770K | Buy |
1,333
+73
| +6% | +$42.2K | 0.37% | 61 |
|
|
2018
Q4 | $353K | Buy |
+1,260
| New | +$353K | 0.22% | 88 |
|